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AbstrAct
Cervical epithelial cell immortalization with defined genetic factors without 
viral oncogenes has never been reported. Here we report that HPV-negative cervical 
epithelial cells failed to be immortalized by telomerase activation or the combination of 
p53 knockdown and telomerase activation. Under those conditions, p16INK4a expression 
was always elevated during the late stage of limited cell lifespan, suggesting that 
cervical epithelial cells possess an intrinsic property of uniquely stringent activation 
of p16INK4a, which may offer an explanation for the rarity of HPV-negative cervical 
cancer. Combining p16INK4a knockdown with telomerase activation resulted in efficient 
immortalization of HPV-negative cervical epithelial cells under ordinary culture 
conditions. Compared with the HPV16-E6E7-immortalized cell lines derived from the 
same primary cell sources, the novel HPV-negative immortalized cell lines had lower 
degrees of chromosomal instability, maintained more sensitive p53/p21 response 
to DNA damage, exhibited more stringent G2 checkpoint function, and were more 
resistant to replication-stress-induced genomic instability. The newly immortalized 
HPV-negative cervical epithelial cell lines were non-tumorigenic in nude mice. The 
cell lines can be used not only as much-needed HPV-negative non-malignant cell 
models but also as starting models that can be genetically manipulated in a stepwise 
fashion to investigate the roles of defined genetic alterations in the development of 
HPV-negative cervical cancer.
IntroductIon
Uterine cervical cancer is one of the most frequently 
occurring cancers in women worldwide [1]. Infection with 
high-risk human papillomavirus (HPV) such as HPV16 
or HPV18 has been identified as a crucial etiological 
factor of at least 90% of cervical cancers [2]. However, 
the mechanisms for the development of HPV-negative 
cervical cancers still remain very poorly understood. The 
well-known oncogenic functions of high-risk HPV include 
the deregulated expression of viral oncogenes E6 and E7, 
which inactivate the master tumor suppressors, p53 and 
Rb proteins, respectively, by accelerating proteolytic 
degradation [3]. In addition, high-risk HPV E6 can also 
activate telomerase in epithelial cells, and interact with 
PDZ proteins (postsynaptic density signaling proteins, 
Drosophila disc large proteins and zonula occludens 
1 proteins) that play critical roles in a variety of cellular 
and molecular processes including those important for cell 
polarity and signal transduction [4]. 
Cellular immortalization is an early and indispensible 
step for cancer development and has been regarded as 
a hallmark of cancer [5]. To date, most immortalized 
cervical epithelial cell lines were established by high-risk 
HPV infection or E6/E7 expression [e.g, 6–11]. Although 
a Rho kinase inhibitor enabled immortalization of human 
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cervical epithelial cells without the expression of viral 
oncogenes, the immortalization needs the continuous 
presence of fibroblast feeder cells [12]. Immortalization of 
human cervical epithelial cells without feeder fibroblasts 
and viral oncogenes has never been reported so far. 
With the application of HPV vaccines, the relative 
ratio of HPV-negative to HPV-positive cervical cancer may 
increase in the future because of the decrease in incidence 
of HPV-induced cervical cancer. The establishment of 
immortalized HPV-negative cervical epithelial cell lines 
may have important applications in the illustration of 
stepwise events leading to HPV-negative cervical cancer 
and in development of targeted therapy. 
Immortalization of human somatic cells requires 
telomere maintenance, either by telomerase activation, 
or in some rare cases by alternative telomere lengthening 
mechanism. Telomerase activation is commonly achieved 
by overexpression of hTERT, the catalytic subunit of 
telomerase. However, up to date, it is still controversial 
whether telomerase activation alone is sufficient 
for immortalization of human epithelial cells or the 
requirements are cell-type/context dependent. Although 
some reports have defined that both inactivation of p16INK4a/
Rb pathway and telomerase activation are necessary and 
sufficient for immortalization of examined epithelial 
cell types [13–15], others reported that inactivation of 
p16INK4a was not required for immortalization of cells 
expressing hTERT as long as the cells were cultured with 
the fibroblast feeder layer [16]. Interestingly, the group 
led by Rheinwald, the initial inventor of fibroblast feeder 
layer system, demonstrated that even under the condition 
of the fibroblast feeder layer, keratinocytes still needed the 
inactivation of p16INK4a and p53 to achieve immortalization 
[17]. In contrast, an esophageal epithelial cell line and a 
pancreatic duct epithelial cell line could be immortalized 
by hTERT expression alone, without the inactivation of 
p16INK4a and without using fibroblast feeder layer [18, 19]. 
Furthermore, data from multiple cell sources showed 
that there were intrinsic differences in the basal levels of 
p16INK4a expression [20]. The cell strains with low basal 
levels of p16INK4a were insensitive to further p16INK4a 
activation, and the senescence in those cell strains could be 
reversed by suppression of telomere-shortening-triggered 
senescence signaling, such as by p53 suppression or hTERT 
overexpression; whereas in those cell strains sensitive 
to p16INK4 activation, the senescence state remained 
irreversible by p53 suppression and telomerase activation 
[20]. This finding offers an explanation why some cell 
strains can be directly immortalized by telomerase 
activation alone whereas others cannot. Importantly, many 
cell-types such as esophageal, mammary, nasopharyngeal, 
prostate, retina pigment epithelial cells, oral keratinocytes, 
foreskin keratinocytes, adenoid epithelial cells, endothelial 
cells, and some strains of human fibroblasts exhibited 
spontaneous loss of p16INK4a expression by p16INK4a gene 
deletion or promoter methylation during prolonged culture 
of hTERT-expressing cells which initially expressed 
high levels of p16INK4a prior to immortalization [13,15, 
20–28]. Given the fact that human cervical cancer are 
unique in that they are highly dependent upon persistent 
high-risk HPV infection, we sought to explore whether 
HPV-negative cervical epithelial cells are intrinsically 
different from those reported cell types in the property of 
persistent activation of p16INK4a expression that hinders 
immortalization without viral oncogene expression.
Our continuous effort in the last 5 years 
demonstrated that HPV-negative cervical epithelial 
cells failed to be immortalized no matter hTERT was 
overexpressed alone or p53 expression was suppressed 
in combination with hTERT overexpression. Under 
those conditions, p16INK4a expression was always 
increased during the late stage of limited cell lifespan. 
The combination of p16INK4a knockdown with hTERT 
overexpression resulted in efficient immortalization of 
HPV-negative cervical epithelial cells under ordinary 
culture conditions. These findings strongly suggest that 
cervical epithelial cells possess an intrinsic property of 
uniquely stringent maintenance of p16INK4a expression, 
which acts as a giant barrier to immortalization without 
HPV oncogene expression. We further found that, when 
compared with the cell lines immortalized by expressing 
HPV16 E6E7, the HPV-negative immortalized cervical 
epithelial cell lines were genetically more stable, had 
more sensitive response to DNA damage, exhibited more 
stringent G2 checkpoint function, and were more resistant 
to replication-stress-induced genomic instability. The 
HPV-negative immortalized cervical epithelial cell lines 
were non-tumorigenic in nude mice. Revelation of genetic 
elements for immortalization of HPV-negative cervical 
epithelial cells has important implications for the pre-
cancer stage of poorly understood HPV-negative cervical 
neoplastic transformation.  
results
Human uterine cervical epithelial cells 
were unable to be immortalized by htert 
overexpression alone 
We have been involved in immortalization of 
multiple types of epithelial cells using various genetic 
elements [11, 26, 27, 29, 30], and have immortalized 
multiple esophageal and nasopharyngeal epithelial cell 
lines by overexpression of hTERT alone without using 
feeder fibroblasts [26, 27, 30]. Of note, those hTERT-
immortalized cell lines were established after the cells 
acquired spontaneous loss or expression of low levels of 
p16INK4a. We therefore tested whether cervical epithelial 
cells had the same capacity of immortalization by 
overexpression of hTERT alone without using feeder 
fibroblasts. The primary cell sources (designated as 
NC104, NC105, NC106 and NC107) were cultured 
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from normal uterine cervical tissues donated by 4 
independent individuals. Without introduction of any 
ectopic genetic factors, the four parental cell strains had 
a maximum lifespan of 14 population doublings (PD) 
after the first passage in culture. We then used retroviral 
vectors expressing hTERT to activate telomerase in the 
four cell strains at PDs 4–8 when the cells were at the 
stage of active proliferation (the same method as we used 
before for esophageal and nasopharyngeal epithelial cell 
immortalization [26, 27, 30]). Telomerase activity was 
quantified by using enzyme-linked immunosorbent assay-
based telomeric repeat amplification protocol (ELISA-
TRAP). We confirmed that telomerase was successfully 
activated by hTERT overexpression compared with 
primary proliferating cells (Figure 1A). The levels of 
activated telomerase activity in all four hTERT-expressing 
cervical cell strains reached at the similar level with our 
previously immortalized nasopharyngeal epithelial cell 
line by hTERT overexpression (NP460-hTERT).  For the 
last 5 years, we have cultured an average of twenty T-75 
flasks of hTERT-expressing cervical epithelial cells for 
each of the four cell strains (~ 1 × 107 cells in each flask 
resistant to drug selection for hTERT overexpression). 
Although lifespans of the cells were extended by limited 
population doublings, none of the cultures resulted in 
immortalization (Table 1). In each culture flask, the cells 
eventually entered into a plateau stage, during which the 
cell numbers stopped increasing, and eventually all cells 
acquired enlarged cell sizes, the typical morphology of 
cellular senescence. We cultured the cells at senescence 
in flasks as long as possible (for an average of 4 months) 
with fresh medium replacement every 3 days to see if 
some rare cells could acquire proliferative capacity. 
However, eventually all of the cells became detached from 
the flasks and died out. As examples, the typical growth 
curves of NC104-hTERT and NC105-hTERT are shown 
in Figure 1B and 1C. Compared with our previous success 
in hTERT-mediated immortalization of other types of 
epithelial cells [26, 27, 30], our five years of continuous 
effort on multiple cervical epithelial cell strains led us to 
conclude that human cervical epithelial cells are generally 
unable to be immortalized by hTERT overexpression 
alone.
Persistent increase in p16InK4a expression in 
htert-expressing cervical epithelial cells at late 
stage of cell lifespan   
It has been shown that there are intrinsic differences 
among some cell types or cell strains in the ability to 
induce p16INK4a expression at senescence [20]. The 
increase in p16INK4a expression is believed to be a sensitive 
response to stress in vitro as well as in vivo. After the cells 
enter the p16INK4a/Rb-mediated senescence, neither ectopic 
p53 inactivation nor subsequent p16INK4a/Rb inactivation 
combined with hTERT overexpression can rescue the 
senescence phenotype [20]. This correlates with the 
finding that an irreversible repressive heterochromatin 
state is established by p16INK4a/Rb activation [31]. 
However, in many cell types [13, 15, 20–28], some 
hTERT-expressing cells expressed low levels of p16INK4a or 
lost p16INK4a expression, and eventually became dominant 
in culture, leading to immortalization. Yet our Western 
Blotting analysis consistently revealed sharp increases in 
the protein expression of p16INK4a in all cultures of hTERT-
expressing cervical epithelial cells at the late stage of 
senescence compared with that at the early pre-senescence 
stage, as exemplified by the typical data in Figure 2A. The 
expression levels of total p53 and phosphorylated p53 
(at Ser- 15, the active form), did not showed remarkable 
differences between the early and the late stage of the 
cells’ lifespan (Figure 2A). Therefore we conclude that 
cervical epithelial cells have an intrinsic property of 
stringent maintenance of p16INK4a activation at senescence. 
This is consistent with our observation that there has been 
no any immortalized clone of hTERT-expressing cervical 
epithelial cells that could emerge from senescence in a 
total of 83 cultures of 4 cell strains (Table 1).  
p53 suppression plus htert expression was 
unable to immortalize cervical epithelial cells 
The suppression of p53 in combination with hTERT 
expression has been reported to be able to immortalize 
ovarian surface epithelial cells [32]. It is of interest to 
test whether the similar finding could be obtained in 
cervical epithelial cells.  We performed p53 knockdown 
using retroviral vectors expressing short hairpin RNA 
against p53 to inactivate p53 (the same vectors as for 
ovarian surface epithelial cell immortalization [32]) 
in combination with hTERT expression in NC104 
and NC105 cells. The successful suppression of p53 
expression was confirmed by Western Blotting analysis 
(Figure 2B). Strong telomerase activity was also detected 
(Figure 1A). However, p53 suppression plus hTERT 
overexpression failed to induce immortalization in both 
cervical epithelial cell strains. Actually, the lifespans 
(population doublings) of the cells were not remarkably 
extended by the combination of p53 knockdown with 
hTERT expression compared with the cells expressing 
hTERT alone (Figure 1B and 1C).  Of note, the cells 
with p53 knockdown and hTERT expression exhibited 
increased levels of p16INK4a at the late stage of their 
lifespan compared with their early lifespan (Figure 2C). 
Efficient immortalization of cervical epithelial 
cells by knockdown of p16InK4a in combination 
with htert overexpression 
To test whether p16INK4a activation truly functions 
as the dominant barrier to immortalization of cervical 
epithelial cells, we infected the proliferative cervical 
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epithelial cells (NC104 and NC105) at PD 4 with lentiviral 
vectors expressing short hairpin RNA against p16INK4a 
(shp16) to suppress p16INK4a expression [20] and retroviral 
vectors expressing hTERT. This combination resulted 
in vigorous continuous cell proliferation far beyond the 
original lifespan of the parental cells. So far, the two cell 
lines, designated as NC104-shp16-hTERT and NC105-
shp16-hTERT, have undergone over 100 PD without 
any signs of crisis or a slow growth phase, as shown by 
growth curves in Figure 1B and 1C. Because the lifespans 
have been extended for more than 50 PD beyond the 
original lifespans without any signs of slowing down 
in growth rates, the two novel cell lines are regarded as 
immortalized according to the published criteria [17]. The 
increased hTERT protein expression, the decreased p16 
expression (Figure 3A), and the strong telomerase activity 
was confirmed in both shp16-hTERT-immortalized cell 
lines as compared with their parental cells (Figure 1A). 
Short tandem repeat (STR) analysis at eighteen loci 
showed that  NC104-shp16-hTERT and NC105-shp16-
hTERT cell lines had distinct STR profiles, confirming 
that they were derived from independent cell sources 
(Supplementary information, Supplementary Figures S1 
and S2). As expected, identical STR profiles were found 
in our newly established NC104-shp16-hTERT cell line 
and the previously immortalized NC104-E6E7 cell line 
table 1: Attempts of immortalization of cervical epithelial cells by htert overexpression 
cell strain Number of flasks cultured
number of immortalized 
clones
Average lifespan  
(population doubling  ± sd)*
NC104-hTERT 23 0 24 ± 2
NC105-hTERT 22 0 26 ± 2
NC106-hTERT 18 0 20 ± 1
NC107-hTERT 20 0 22 ± 2
*Standard deviatation.
Figure 1: telomerase and growth curves of cervical epithelial cells after introduction of different genetic factors. (A) 
Telomerase activity (relative to “low activity” controls provided by the manufacturer) quantified according to protocols of TeloTAGGG 
Telomerase PCR ELISA kits. Error bars indicate standard deviations from 3 duplicates. (b and c) Growth curves of cervical epithelial cells 
with or without introduction of different genetic factors. 
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[11] because they were established from the same parental 
cell source. The same is true in NC105-shp16-hTERT 
and NC105-E6E7 cell lines (Supplementary Figures S1 
and S2). Our RT-PCR analysis demonstrated that both 
NC104-shp16-hTERT and NC105-shp16-hTERT cell 
lines did not express HPV E6 and E7 genes, in contrast 
to NC104-E6E7 and NC105-E6E7 cell lines that were 
previously immortalized by HPV16 E6E7 (Supplementary 
Figure S3). These results clearly demonstrate that the 
maintenance of extremely stringent p16INK4a activation 
is indeed a crucial barrier to immortalization of HPV-
negative cervical epithelial cells.
the newly immortalized cervical epithelial cell 
lines retained typical cytokeratin characteristic 
of cervical epithelial cells
The immortalized NC104-shp16-hTERT and 
NC105-shp16-hTERT cell lines showed typical cuboidal 
morphology, which is characteristic of proliferative 
epithelial cells (Figure 3B and 3C). Western Blotting 
analysis was carried out to detect the expression of some 
typical epithelial cell cytokeratins. Cytokeratin 5/8, 
13, 18 and 19 were detected in NC104-shp16-hTERT 
and NC105-shp16-hTERT cell lines (Figure 4A). The 
expression pattern is in agreement with the cytokeratin 
expressions in previously reported high-risk-HPV- or 
E6E7-immortalized cervical epithelial cell lines [6, 
10]. As a control for our analysis, HeLa cancer cell line 
expressed cytokeratin 5/8, 18 and 19, but not cytokeratin 
13, in consistence with the reported results in HeLa cell 
line [10]. In contrast, the cytokeratin expression was not 
detected in the fibroblast cell line FS-2, which served as a 
negative control.
Alterations in gene expressions in p16InK4a/rb 
and p53/p21 pathways
As mentioned above, our Western Blotting analysis 
demonstrated that p16INK4a expression was successfully 
knocked down in NC104-shp16-hTERT and NC105-
shp16-hTERT cell lines compared with their respective 
proliferative parental cells (Figure 3A). For comparison, 
the HPV16 E6E7-immortalized cell lines expressed 
higher levels of p16INK4a protein than parental cells, in 
agreement with previous findings in other HPV- or E6E7-
immortalized cell lines [33, 34]. The increased p16INK4a 
expression in E6E7-expressing cells could be explained 
by the negative regulation of p16INK4a by Rb [35]. 
Interestingly, the shp16-hTERT-immortalized cervical 
epithelial cell lines expressed higher levels of Rb than 
respective proliferative parental cells (Figure 3A). This 
is similar with the observation in hTERT-immortalized 
foreskin and adenoid keratinocytes accompanied with 
spontaneous loss of p16INK4a expression [21]. Although 
cyclin D1 is a known downstream target of p16INK4a/Rb 
pathway, we observed no obvious change in the expression 
levels of cyclin D1 in the shp16-hTERT-immortalized cell 
lines, indicating the complex regulation of cyclin D1 [21]. 
There were no significant changes in expression levels of 
p53 and p21 after shp16-hTERT-mediated immortalization 
when compared with those in parental cells. This is in line 
with our result that the suppression of p53 is not required 
for immortalization of cervical epithelial cells once p16INK4a 
expression was suppressed and telomerase was activated. 
For comparison, the clearly lower levels of p53 and p21 
expression were detected in HPV16-E6E7-immortalized 
cell lines when compared with parental cells (Figure 3A). 
Figure 2: Western blotting analysis for protein expression of p16InK4a, p53, and actin that served as protein loading 
controls.  
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Karyotypic analysis 
Twenty-four color spectral karyotyping (SKY) 
was performed to analyze whole-genome chromosomal 
abnormalities of the shp16-hTERT-immortalized cervical 
epithelial cell lines and their parental cells. At an early 
population doubling (PD 30), a normal karyotype was 
observed in the majority of shp16-hTERT-immortalized 
cells, and trisomy 20 or trisomy 7 was detected as a minor 
clone in NC104-shp16-hTERT and NC105-shp16-hTERT 
cell lines, respectively (Table 2). At PD80, a stable near-
diploidy with trisomy 20 was observed in the majority 
(~ 80%) of NC104-shp16-hTERT cells (Figure 4B and 
Table 2). In NC105-shp16-hTERT cells, a stable near-
diploidy containing trisomy 7, an extra iso-chromosome 
composed of 8q, and a derivative chromosome 17, was 
detected in ~ 90% of metaphases at PD 80 (Figure 4C 
and Table 2). Parental NC104 and NC105 cells at PD 
4 had normal diploid karyotype. Therefore, the clonal 
chromosomal alterations in the immortalized cell lines 
were acquired during immortalization. Compared 
with clonal chromosomal aberrations in previously 
immortalized NC104-E6E7 and NC105-E6E7 cell lines 
at the same PD (Table 2), the shp16-hTERT-immortalized 
cells had fewer clonal aberrations, in particular, 
fewer clonal numerical abnormalities. In addition, the 
frequencies of  non-clonal chromosome aberrations, an 
indicator of continuous chromosomal instability, in both 
shp16-hTERT-immortalized cell lines were significantly 
lower than those in HPV16-E6E7-immortalzed epithelial 
cell lines (P < 0.05) (Supplementary Table S1). These 
results indicated that the shp16-hTERT-immortalized 
cervical epithelial cell lines had lower degrees of genetic 
instability than HPV16-E6E7-immortalzed counterparts. 
dnA damage response 
One of sensitive and pivotal responses to DNA 
damage is the activation of p53/p21 pathway, which plays 
important roles in tumor suppression and is thus frequently 
inactivated in many types of cancer [5]. We therefore 
examined the response of p53 and p21 to DNA damage 
Figure 3: Protein expression of immortalization-related genes and morphology of immortalized cervical epithelial cells. 
(A) Western blotting analysis for protein expression of hTERT and cell cycle regulation genes in primary, shp16-hTERT-immortalized, and 
HPV16-E6E7-immortalized cervical epithelial cells. (B and C) Typical morphology of immortalized cervical epithelial cells. 
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in the shp16-hTERT-immortalized cervical epithelial 
cell lines and compared with that in HPV16-E6E7-
immortalized cell lines. We used a low dose (0.5 Gy) 
of γ-ray irradiation to examine if a sensitive differential 
response to a low level of DNA damage could be detected. 
Two hours after irradiation, the expression levels of 
phosphorylated p53 (at Ser-15) (the active form of p53) 
and p21 (the downstream target of p53 activation) showed 
remarkable increase in both shp16-hTERT-immortalized 
cell lines, although there were some differences between 
the two cell lines in the increased levels of two proteins 
(for unknown reasons) (Figure 5A). No obvious change 
in the total levels of p53 was detected (Figure 5A), 
indicating that phosphorylated p53(Ser-15) and p21 are 
more sensitive responders to DNA damage than total 
levels of p53. It is possible that the high basal levels of 
total p53 expression in cervical epithelial cells might 
obscure the detection of subtle changes in total levels of 
Figure 4: cytokeratin expression and spectral karyotyping (sKY) analyses of immortalized cell lines. (A) Protein 
expression of typical cervical epithelial cytokeratins in the immortalized cervical epithelial cell lines. HeLa and FS-2 cell lines served as 
positive and negative controls. (b and c) Typical SKY in the newly immortalized cervical epithelial cell lines. Karyotyping descriptions in 
shp16-hTERT and HPV16-E6E7-immortalized cell lines were presented in Table 2.  
table 2: Karyotype descriptions of shp16-htert-immortalized cervical epithelial cell lines in 
comparison with HPV16-e6e7-immortalized counterparts 
cell line (Pd) Karyotype*
NC104-shp16-hTERT (PD 30) 46,XX[41]/47,XX,+20[12]
NC105-shp16-hTERT (PD 30) 46,XX[36]/47,XX,+7[15]
NC104-shp16-hTERT (PD80) 47,XX,+20[40]/94,XXXX,+20,+20[8]
NC105-shp16-hTERT (PD80) 48,XX,+7,+i(8)(q10),der(17)t(5;17)(?q2;p12)[43]/ 96,XXXX,+7,+7,+i(8)(q10)×2,der(17)
t(5;17)(?q2;p12)×2[4]
NC104-E6E7 (PD80) 46,XX,der(20)dup(20)(q?)t(3;20)(q25;q?)[7]/45~48,XX,-2,+5,+7,der(20)dup(20)
(q?)t(3;20)(q25;q?)[cp11]/89~94,XXXX,-2,+5,+6,+7,+8,der(20)dup(20)(q?)t(3;20)
(q25;q?)×2,-22[cp32]
NC105-E6E7 (PD80) 54~57,XX,+1,+2,+5,+5,+6,+7,del(7)(q11),der(8;15)(q10;q10),+9,+13,+18,+20,+20,+21
[cp50]
*The numbers in square brackets indicate cell numbers identified. “cp” in square brackets means composite karyotypes: no 
any cell had all listed aberrations.
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p53 expression in response to a low level of DNA damage. 
For comparison, HPV16-E6E7-immortalzed cell lines 
showed barely detectable increase in the expression levels 
of phosphorylated p53 and p21 two hours after the γ-ray 
irradiation. These results together demonstrated that the 
shp16-hTERT-immortalized cervical epithelial cell lines 
maintained sensitive responses to DNA damage. 
Function of G2 checkpoint 
G2 checkpoint is essential for the maintenance 
of genomic integrity. Previous studies revealed that 
the expression of HPV16-E6E7 in human fibroblasts 
and foreskin keratinocytes induced deficiency in G2 
checkpoint function [36, 37]. Here we utilized the 
unique opportunity of comparing the immortalized HPV 
oncogene-negative and -positive cervical epithelial cell 
lines derived from the same parental cell sources to 
examine the differential G2 checkpoint function. If the 
cells have functional G2 checkpoint, the G2 phase cells 
will be arrested at G2 phase after DNA damage, while 
mitotic cells are relatively insensitive to DNA damage thus 
will continue exiting from mitosis after low doses (< 1 
Gy) of γ-ray irradiation, leading to the decrease in mitotic 
index (percentage of mitotic cells) several hours after 
γ-ray irradiation. The mitotic cells could be accurately 
identified by individual chromosome condensation using 
chromosome spreading technique. The proficiency of 
G2 checkpoint function could be readily analyzed by 
the ratio of mitotic index 2 – 3 hr after γ-ray irradiation 
relative to the mitotic index of un-irradiated cells. This 
has been termed as relative mitotic index [38–40]. A 
lower relative mitotic index indicates more stringent G2 
checkpoint function. By using this method, we found 
that the shp16-hTERT-immortalized cell lines exhibited 
more stringent G2 checkpoint function as evidenced 
by the significantly lower relative mitotic indices than 
HPV16-E6E7-immortalized cell lines 2 hr after 0.5 Gy 
Figure 5: response of p53 and p21 to ionizing radiation and G2 checkpoint function analysis in shp16-htert-
immortalized and HPV16-e6e7-immortalized cervical epithelial cell lines. (A) Western blotting analysis of p53, phospho-53 
and p21 in immortalized cervical epithelial cell lines 2 hr after 0.5 Gy γ-ray irradiation. (b) Upper chart: Relative mitotic indices in 
immortalized cervical epithelial cell lines 2 hr after 0.5 Gy γ-ray irradiation (4,000 cells were counted); Lower chart: Frequencies of 
chromatid breaks in immortalized cervical epithelial cell lines 2 hr after 0.5 Gy γ-ray irradiation (100 metaphases were analyzed). Error 
bars indicate standard deviations. *P < 0.05. 
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γ-ray irradiation (P < 0.05) (Figure 5B). Metaphase cells 
that escape from defective G2 checkpoint usually contain 
chromatid breaks [39, 40]. As shown in Figure 5B, both 
shp16-hTERT-immortalized cervical epithelial cell lines 
exhibited significantly lower frequencies of chromatid 
breaks than HPV16-E6E7-immortalized cell lines 2 hr 
after 0.5 Gy γ-ray irradiation. These results demonstrated 
that the shp16-hTERT-immortalized cell lines had more 
stringent G2 checkpoint than HPV16-E6E7-immortalized 
cell lines.  
response to replicative stress
Replication stress-induced chromosomal instability 
has been proposed to be one of the basic mechanisms for 
the induction of genetic alterations in cancers [41, 42]. 
It has been established that the proto-oncogene cyclin E 
overexpression is a potent inducer of replicative stress 
[42, 43]. To characterize the differences between shp16-
hTERT-immortalized and HPV16-E6E7-immortalized 
cervical epithelial cells in response to replicative stress, 
NC104-shp15-hTERT cells and NC104-E6E7 cells at 
PD 80 were infected with retroviral vectors expressing 
cyclin E or empty vectors. The successful overexpression 
of cyclin E was confirmed by Western Blotting analysis 
(Figure 6A) in both cell lines. A pioneer study showed that 
cyclin E overexpression induced dramatic chromosome 
structural aberrations in HPV16-E6E7-expressing human 
fibroblasts while barely induced detectable structural 
aberrations in normal fibroblasts [43]. Here we analyzed 
the metaphases from cyclin-E-overexpressing cervical 
epithelial cells and the control cells (infected with empty 
vectors) for detailed chromosome aberration analysis 
using 24-color SKY. Our results (Figure 6B) showed 
that the frequency of metaphases containing non-
clonal chromosome abnormalities (mainly chromatid 
breaks and fusions) dramatically increased after cyclin 
E overexpression in NC104-E6E7 cells, whereas a 
relatively small extent of increase (P > 0.01) was 
detected in NC104-shp16-hTERT cells after cyclin E 
overexpression. Figure 6C shows an example of NC104-
E6E7 metaphase with numerous chromosome breaks and 
minutes after cyclin E overexpression. Such complex 
chromosome aberrations were not found in NC104-
shp16-hTERT cells after cyclin E overexpression. In 
line with the chromosome aberration analysis results, the 
expression level of phosphorylated Chk1, a classical and 
sensitive response to replicative stress [42,44], showed 
a slight increase in NC104-shp15-hTERT cells while a 
remarkable increase in NC104-E6E7 cells after cyclin E 
overexpression (Figure 6A). These results revealed that 
the shp16-hTERT-immortalized cervical epithelial cells 
were more resistant to replication stress-induced genetic 
instability compared with the counterparts immortalized 
by HPV16-E6E7. 
transformation phenotype analysis
Analysis of transformation phenotype is important 
for characterization of immortalized cell lines. The 
NC104-shp16-TERT, NC105-shp16-hTERT, and their 
HPV16-E6E7-immortalized counterparts, NC104-E6E7 
and NC105-E6E7 cells, were examined for transformation 
phenotypes at PD 100 by both in vitro soft agar colony 
formation assay and in vivo tumorigenicity assay. We 
found that none of the immortalized cell lines were able 
to form colonies in soft agar (Supplementary Figure S4), 
demonstrating that the immortalized cell lines did not 
acquire anchorage-independent growth ability, which is 
a crucial characteristic of transformed phenotype. As the 
positive control, HeLa cells readily formed colonies in 
soft agar (Supplementary Figure S4). The shp16-hTERT-
immortalized and E6E7-immortalized cells were injected 
into nude mice to monitor tumorigenicity. All four cell 
lines failed to form tumors in nude mice after 4 months 
observation, whereas HeLa cells showed tumor formation 
in nude mice by week 3. These results together showed 
that the immortalized cell lines did not show transformed 
phenotype.
dIscussIon
There are several novelties in this study. First, to our 
knowledge, this is the first report on the immortalization 
of HPV-negative cervical epithelial cell lines without 
culturing with feeder fibroblasts.   
Second, we found that, in contrast to many other cell 
types (including those reported by our laboratories) that 
can be immortalized by hTERT overexpression alone after 
spontaneous selection of cells with loss or expression of 
a low level of p16INK4a [13,15, 18–28], cervical epithelial 
cells maintain the capacity of extremely stringent 
activation of p16INK4a. It is worthwhile to emphasize that 
we have been continuously culturing hTERT-expressing 
cervical epithelial cells for the last 5 years and have 
attempted a total of 83 cultures of 4 cell strains. However, 
none of the cultures resulted in an immortalized cell 
line. The cells at senescence stage persistently expressed 
increased levels of p16INK4a. This tight maintenance of 
p16INK4a activation in HPV-negative cervical epithelial 
cells has not been reported before and may represent a 
unique intrinsic property of cervical epithelial cells. This 
property of cervical epithelial cells may shed light on the 
reason why HPV-negative cervical cancer is rare. We have 
achieved efficient immortalization of cervical epithelial 
cells by ectopic knockdown of p16INK4a expression in 
combination with hTERT overexpression, confirming 
that p16INK4a activation is indeed a functional barrier to 
immortalization of cervical epithelial cells. Knockdown 
of p53 in combination with hTERT overexpression was 
unable to induce immortalization of cervical epithelial 
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cells, suggesting that p16INK4a inactivation may play a 
more important role than p53 inactivation in early process 
of pre-cancer transformation of cervical epithelial cells 
without HPV oncogenes. Since the mechanisms underlying 
the development of HPV-negative cervical cancer are 
currently poorly understood, the newly immortalized 
cervical cell lines without using HPV oncogenes can serve 
as valuable pre-malignant cell models in the stepwise 
illustration of events leading to HPV-negative cervical 
cancerous transformation. The newly immortalized 
cervical epithelial cell lines are relevant to the studies on 
HPV-negative cervical cancer development because most 
HPV-negative cervical cancer lost or exhibited low levels 
of p16INK4a expression [45,46].  
Third, the availability of HPV-oncogene-negative 
and -positive immortalized cervical epithelial cell lines 
derived from the same original cell sources offered a unique 
opportunity, for the first time, for head-to-head comparative 
studies on functions related to genomic stability. The 
p53/p21 pathway is well-known to play critical roles in 
maintaining genomic stability. The basal expression levels 
of total p53, phosphorylated p53 (Ser- 15), and p21 in 
both shp16-hTERT-immortalized cervical epithelial cell 
lines were remarkably higher than those in HPV16-E6E7-
immortalized counterparts. In addition, a low dose of γ-ray 
irradiation induced significant activation of p53 (indicated 
by phosphorylation at Ser-15) and p21 in shp16-hTERT-
immortalized cervical epithelial cells whereas slight or 
undetectable activation of p53 and p21 in HPV16-E6E7-
immortalized counterparts (Figure 5A). In addition, both 
shp16-hTERT-immortalized cervical epithelial cell lines 
exhibited the proficient G2 checkpoint function, in contrast 
to the defective G2 checkpoint function in HPV16-E6E7-
immortalized cell lines. 
Figure 6: effects of cyclin e overexpression in immortalized cervical epithelial cells. (A) Western blotting analysis of cyclin 
E, Chk1, and phospho-Chk1(S345). Actin serves as protein loading control. (b) Frequencies of non-clonal chromosome aberrations in 
immortalized cervical epithelial cells with cyclin E overexpression or without cyclin E overexpression (infected with retroviruses expressing 
empty vectors) (100 metaphases were analyzed).  Error bars indicate standard deviations. *P < 0.05. (c) An example of NC104-E6E7-
cyclin E metaphases containing numerous chromosome aberrations. Red arrows indicate some of the chromatid breaks.  White arrows 
indicate examples of minutes. Note that many other chromatid breaks and minutes are visible. 
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Fourth, the examination on replication stress-
induced genomic instability in the newly established 
immortalized cell lines is another novelty in this study. 
Replication stress-induced genomic instability has 
been proposed to a basic and important route leading 
to cancer development [41, 42]. Replication stress 
in vivo can be induced by hyper-DNA replication due to 
overexpression of S-phase promoting oncogenes such 
as cyclin E and cyclin A. In this study, we used cyclin 
E overexpression to induce replication stress. Compared 
with HPV16-E6E7-immortalized cells, the shp16-hTERT-
immortalized cervical epithelial cells showed remarkably 
lower degree of Chk1 activation (a sensitive indicator 
of replication stress) after cyclin E overexpression. 
This could be explained by the finding that the ability 
of cyclin E to induce replication stress is suppressed by 
functional p53/21 pathway [43]. In line with this, the 
shp16-hTERT-immortalized cells exhibited dramatically 
lower frequencies of chromosome aberrations than 
HPV16-E6E7-immortalized counterparts after cyclin E 
overexpression (Figure 6B). These results suggest that the 
shp16-hTERT-immortalized cervical epithelial cells had 
a much better defence against replication-stress-induced 
genomic instability than HPV16-E6E7-immortalized 
counterparts.  
Karyotype analysis showed that shp16-hTERT-
immortalized cervical epithelial cell lines had fewer clonal 
chromosomal abnormalities than respective HPV16-E6E7-
immortalized counterparts analyzed at PD80 (Table 2). 
Although minor near-tetraploid clones derived from the 
whole-genome duplication of the near-diploidy were 
detected in both shp16-hTERT-immortalized cervical 
epithelial cell lines at PD80, the near-tetraploid cells were 
stably expanded, which was indicated by completely 
identical karyotypes in the minor clones. Such stability 
in the expansion of near-tetraploidy was not observed 
in HPV16-E6E7-immortalzied cell lines, in which no 
completely identical near-tetraploidy was found. This is 
indicated by the “composite karyotype” [cp] in Table 2. 
In NC105-E6E7 cell line which was still near-diploid, 
no analyzed cells contained the completely identical 
karyotypes, indicating a high level of genomic instability. 
Moreover, non-clonal structural and numerical aberrations 
were detected at much lower frequencies in shp16-hTERT-
immortalized cervical epithelial cell lines compared with 
respective HPV16-E6E7-immortalized counterparts 
(Supplementary Table S1), further demonstrating that 
shp16-hTERT-immortalized cervical epithelial cell lines 
had lower degrees of genomic instability than HPV16-
E6E7-immortalized counterparts. Interestingly, the minor 
clone with trisomy 20 or trisomy 7 observed at PD30 in 
NC104-shp16-hTERT and NC105-shp16-hTERT cell 
line, respectively, became dominant at PD80. In NC105-
shp16-hTERT cells at PD80, the dominant clone had 8q 
isochromosome. These chromosomal alterations  were 
also previously observed in multiple other cell types 
immortalized by non-viral genetic factors [14, 27, 47]. 
The common findings suggest that those chromosomal 
alterations may provide a general growth advantage to 
immortalized cells, although it is unknown if they are 
definitely required for immortalization. 
For tumorigenic transformation, it is known that 
multiple potent oncogenes are required. As expected, 
our shp16-hTERT-immortalized and HPV16-E6E7-
immortalized cervical epithelial cell lines did not show 
tumorigenic phenotype, in agreement with most of 
previous reports of immortalized cell lines tested for 
transformation properties [e.g., 6–9, 21, 22, 25, 27].
In summary, we have revealed, for the first time, 
that cervical epithelial cells are different from many 
other reported cell types in that cervical epithelial cells 
possess the intrinsic characteristic of extremely stringent 
activation of p16INK4 expression without HPV oncogene 
expression. This unique property of cervical epithelial 
cells may shed light on the reasons why HPV-negative 
cervical cancer is rare. We have successfully immortalized 
the first set of HPV-negative cervical epithelial cell lines 
without using feeder fibroblasts by knockdown of p16INK4a 
in combination with hTERT overexpression. When 
compared with HPV16-E6E7-immortalized counterparts, 
the novel HPV-negative immortalized cervical epithelial 
cells had lower degrees of chromosomal instability, more 
sensitive response to DNA damage, more stringent G2 
checkpoint, were more resistant to replication stress-
induced chromosome aberrations. The shp16-hTERT-
immortalized and HPV16-E6E7-immortalized cervical 
epithelial cell lines were non-tumorigenic in nude mice. 
The newly immortalized cervical epithelial cell lines can 
be used not only as much-needed HPV-negative non-
malignant control models in studies on novel functions 
of HPV oncogenes but also as starting models that can 
be genetically manipulated in a stepwise fashion to 
investigate the roles of defined genetic alterations in 
the development of HPV-negative cervical cancers. The 
cell models with defined genetic alterations may be 
particularly useful in testing preventive or therapeutic 
drugs that have specificity against proteins encoded by 
defined altered genes. 
MAterIAls And MetHods
cell culture
The same primary normal cervical epithelial cells 
(NC104 and NC105) as we previously reported [11] 
were used to establish novel immortalized cell lines. Our 
HPV16-E6E7-immortalized cervical epithelial cell lines 
(NC104-E6E7 and NC105-E6E7) [11] were used for 
comparative studies. The epithelial cells were cultured in 
serum-free media as described [11]. No feeder fibroblasts 
were used for cell culture. HeLa cells were cultured in 
DMEM supplemented with 10% fetal bovine serum. 
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Vectors and viral infection
The lentiviral vectors expressing short hairpin RNA 
against p16INK4a and the empty vectors were a kind gift from 
Prof. J Campisi (Lawrence Berkeley National Laboratory, 
USA) [20]. The retroviral vector pLXIN-hTERT and the 
empty vectors were kindly provided by Dr. J.C. Barrett 
(Laboratory of Molecular Carcinogenesis, National Institute 
of Environmental Health Sciences, USA) [48]. The retroviral 
vector expressing short hairpin RNA against p53 was kindly 
provided by Dr. J. Liu (The University of Texas M. D. 
Anderson Cancer Center, USA) [32].  The retroviral vector 
pBabe-Cyclin E and the empty vectors were kindly provide 
by Dr.  Bruce E Clurman (University of Washington School 
of Medicine Seattle, USA) [43]. The 293T and phoenix-293 
cells were used to produce infectious lentiviruses and 
retroviruses, respectively. The primary cervical epithelial 
cells at PD 4 were infected with the lentiviruses for p16INK4a 
knockdown or retroviruses for hTERT overexpression. In 
addition, the cervical epithelial cells after stable p16INK4a 
knockdown were re-infected at PD 12 with retroviruses 
expressing hTERT.  Stable gene expression or knockdown 
was achieved by appropriate drug selection. 
spectral karyotyping (sKY)
Metaphases were harvested and chromosome 
spreads prepared as described [11]. Fifty to 100 
metaphases were analyzed using SKY for chromosome 
aberrations as previously reported [49]. The International 
System for Human Cytogenetic Nomenclature (1995) was 
applied for karyotype description. 
Western blotting analysis
For each sample, 20 microgram protein from whole-
cell extracts was loaded for Western blotting analysis as 
described [27]. The primary antibodies against p16INK4a 
(Ab4-JC2) was from Neomarkers (Fremont, CA); 
antibodies against Rb, p21, cyclin E, hTERT and actin 
were from Santa Cruz Biotechnology (Santa Cruz, CA); 
anti-p53 was from DakoCytomation (Glostrup, Denmark); 
anti-cyclin D1 (DCS-6) was from BD PharMingen (San 
Jose, CA); antibodies against phospho-p53(ser-15), CHK1 
and phospho-CHK1(ser-345) were from Cell Signaling 
Technology (Danvers, MA); antibodies against cytokeratins 
18 and 19 were from Novocastra Laboratories Newcastle, 
UK); antibodies against cytokeratin cytokeratins 5/8 and 
13 were from Chemicon (Temecula, CA).
reverse transcription (rt)-Pcr for HPV16 e6 
and e7
Qiagen RNeasy Mini Kit (Qiagen, Hilden, 
Germany) was used for total RNA extraction according 
to the manufacture’s instruction. RT-PCR analysis for 
HPV16-E6 and E7 was performed as reported [11]. 
telomerase activity measurement
Telomerase activity was analyzed by 
using TeloTAGGG Telomerase PCR ELISA kits 
purchased from Sigma-Aldrich (St. Louis, MO). The 
quantification of telomerase activity (relative to “low 
activity” controls provided by the manufacturer) was 
carried out by following the manufacturer’s protocols. 
One microgram of extracted protein was used for each 
sample.   
Irradiation
One day before irradiation, the culture media were 
refreshed, and the cells were allowed to reach about 80% 
confluence. The γ-ray irradiation was carried out at a 
dose rate of 10 Gy/min in a GammaCell 220 irradiator 
containing a 137Cs radiation source (Atomic Energy of 
Canada Ltd).
chromosome spreading for mitotic index 
analysis
Cells were harvested without any microtubule 
inhibitors. Chromosome spreads were prepared using 
our published protocols [50]. Cells with distinguishable 
individual chromosome spreads were identified as mitotic 
cells. For each experimental point, 4,000 cells were 
counted for the frequency of mitotic cells. 
soft-agar colony formation assay and 
tumorigenicity in nude mice
For soft-agar colony formation assay, 5 × 104 cells 
were plated onto 6-well plate with 0.3% Bacto-agar with 
serum-free media above a solidified layer of 0.6% agar-
base of the same mixture. Colonies were counted as 
described [27]. For tumorigenicity assay in nude mice, 
107 cells were resuspended in the 0.1 ml 1:1 mixture 
of growth media and Matrigel™ Basement Membrane 
Matrix (BD Biosciences) for subcutaneous injection 
into the flank of 6–8 week-old nude mice. The growth 
of tumor was monitored weekly for up to 4 months after 
injection. 
statistical analysis
Statistical differences were analyzed using the two-
tailed T-test. P values < 0.05 were regarded as significant. 
Error bars in all bar graphs represent standard deviations.
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